Clinical Trial Update: Magnetic Jejuno-Ileal Diversion Study ("MJI Study") [NA]

View source ↗

Summary

Magnetic Jejuno-Ileal Diversion (MJI) trial sponsored by GT Metabolic Solutions has completed, investigating obesity and Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Snippet

Sponsor: GT Metabolic Solutions, Inc. | Conditions: Obesity, Type 2 Diabetes | NA | Status: COMPLETED